New Cardiac Stem Cell Therapy passes Phase I/II TrialsLabiotech.eu (blog)TiGenix announces positive one-year results for its phase I/II trial of donor-derived cardiac stem cell therapy in acute myocardial infarction (AMI). The Belgian biotech TiGenix i… Continue reading
Labiotech.eu (blog) |
This Dutch Company is Upgrading ADCs for Immunotherapy
Labiotech.eu (blog) T-Guard is CEO and co-founder Ypke van Oosterhout’s life work. He told us about the technology that he has been developing since his graduate studies. It was during his post-MSc research that Ypke van Oosterhout ‘discovered’ T-Guard, a technology which … |
|
Belgium’s Tigenix says heart attack stem cell trial successful
WHTC BRUSSELS (Reuters) – Belgian biotech group Tigenix said on Monday its medical trial with a novel treatment for patients at risk of heart failure after a coronary attack was successful. The group said patients treated in its PhaseI/II trial of donor … |
The Times |
Belgium’s Tigenix says heart attack stem cell trial successful
Reuters The group said patients treated in its PhaseI/II trial of donor-derived expanded cardiac stem cells (AlloCSC) showed no side-effects and all of them continued to live after 30 days, six months and a year. Tigenix added that in one subgroup of trial … TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial InfarctionYahoo Finance |
Medical News Today |
Vitamin C can target and kill cancer stem cells, study shows
Medical News Today “We have been looking at how to target cancer stem cells with a range of natural substances including silibinin (milk thistle) and CAPE, a honey-bee derivative, but by far the most exciting are the results with vitamin C. Vitamin C is cheap, natural … |
Wall Street Pit |
This Breakthrough Approach In Gene Therapy Can Potentially Revolutionize Our Fight Against Cancer and HIV
Wall Street Pit Developed by scientists at Fred Hutchinson Cancer Research Center in Seattle and led by Dr. Jennifer Adair, the novel treatment is being referred to as ‘gene therapy in a box’. It is designed to deliver potential HIV and cancer treatments to the … |